Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Bintrafusp Alfa (M7824) Monotherapy in Metastatic or Locally Advanced Urothelial Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating bintrafusp alfa (M7824) monotherapy in metastatic or locally advanced urothelial cancer has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms
• Urothelial Cancer

Drugs mentioned

• Bintrafusp alfa (bintrafusp alfa)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Neoplasms | Phase 1 | Status: TERMINATED | Results posted: 2024-04-18